Clinical Study of Mouse Nerve Growth Factor for Injection Combined with Oxiracetam in the Treatment of Hypertensive Cerebral Hemorrhage

YU Haiyong; ZHANG Ying; SHI Yanghong

doi:10.14009/j.issn.1672-2124.2020.08.017

您当前的位置：

首页 >

文章列表页 >

Clinical Study of Mouse Nerve Growth Factor for Injection Combined with Oxiracetam in the Treatment of Hypertensive Cerebral Hemorrhage

更新时间：2022-10-08

- Clinical Study of Mouse Nerve Growth Factor for Injection Combined with Oxiracetam in the Treatment of Hypertensive Cerebral Hemorrhage
- Vol. 20, Issue 8, Pages: 960-964(2020)
- 作者机构：
  
  1. 朝阳市第二医院神经内科
  2. 榆林市第一医院神经内科
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2020.08.017
  CLC： R743.34
- Published：2020，
扫描看全文
[1]于海永,张颖,师仰宏.注射用鼠神经生长因子联合奥拉西坦治疗高血压脑出血的临床研究[J].中国医院用药评价与分析,2020,20(08):960-964.

YU Haiyong, ZHANG Ying, SHI Yanghong. Clinical Study of Mouse Nerve Growth Factor for Injection Combined with Oxiracetam in the Treatment of Hypertensive Cerebral Hemorrhage. [J]. 20(8):960-964(2020)
[1]于海永,张颖,师仰宏.注射用鼠神经生长因子联合奥拉西坦治疗高血压脑出血的临床研究[J].中国医院用药评价与分析,2020,20(08):960-964. DOI： 10.14009/j.issn.1672-2124.2020.08.017.

YU Haiyong, ZHANG Ying, SHI Yanghong. Clinical Study of Mouse Nerve Growth Factor for Injection Combined with Oxiracetam in the Treatment of Hypertensive Cerebral Hemorrhage. [J]. 20(8):960-964(2020) DOI： 10.14009/j.issn.1672-2124.2020.08.017.

摘要

目的:探讨注射用鼠神经生长因子联合奥拉西坦治疗高血压脑出血（hypertensive cerebral hemorrhage

HCH）的临床效果。方法:选取2017年10月至2019年1月朝阳市第二医院收治的HCH患者92例

采用简单随机数字表法将其分为观察组（n=46）和对照组（n=46）。对照组患者给予奥拉西坦治疗

观察组患者在此基础上加用注射用鼠神经生长因子辅助治疗

两组患者均治疗21 d。治疗结束后

对两组患者的临床疗效进行评估;并于治疗前后测评两组患者神经功能缺损程度及日常生活活动能力

检测血清脑损伤生物标志物、炎症因子及氧化应激指标水平;同时观察两组患者用药期间不良反应发生情况。结果:观察组患者的总有效率为93.48%（43/46）

与对照组的76.09%（35/46）相比明显升高

差异有统计学意义（P<0.05）。两组患者治疗后美国国立卫生院卒中神经功能缺损评分量表（national institutes of health stroke scale

NIHSS）评分均较治疗前明显降低

Barthel指数（BI）评分明显升高;治疗后

观察组患者NIHSS评分较对照组同期明显更低

而BI评分明显更高

差异均有统计学意义（P<0.05）。两组患者治疗后血清脑损伤标志物（神经元特异性烯醇化酶、S100β蛋白）及相关炎症因子（白细胞介素8、肿瘤坏死因子α及超敏C反应蛋白）水平均较治疗前明显降低（P<0.05）

而观察组患者降低更显著

差异均有统计学意义（P<0.05）。两组患者治疗后血清超氧化物歧化酶（SOD）水平均较治疗前明显升高

血清丙二醛（MDA）、脂质过氧化物（LPO）含量明显降低;且治疗后

观察组患者血清SOD水平明显高于对照组同期

血清MDA、LPO含量则明显更低

差异均有统计学意义（P<0.05）。观察组患者不良反应发生率为15.22%（7/46）

与对照组的17.39%（8/46）比较

差异无统计学意义（P>0.05）。结论:注射用鼠神经生长因子联合奥拉西坦治疗HCH可能通过下调患者相关炎症因子表达水平、纠正机体氧化应激的途径来保护脑组织

促进受损神经功能的恢复

整体疗效显著

且患者耐受性较好。

Abstract

OBJECTIVE:To investigate the clinical effects of mouse nerve growth factor for injection combined with oxiracetam in the treatment of hypertensive cerebral hemorrhage（HCH）.METHODS:Totally 92 patients with HCH admitted into Chaoyang the Second Hospital from Oct.2017 to Jan.2019 were extracted to be divided into the observation group（n = 46） and the control group（n = 46） via the random number table.The control group was treated with oxiracetam

while the observation group received mouse nerve growth factor for injection.Patients in both groups were treated for 21 d.After treatment

the clinical efficacy of two groups was evaluated.The degree of neurological impairment and activities of daily living were evaluated before and after treatment

and the levels of serum brain injury biomarkers

inflammatory factors and oxidative stress indicators were detected.Meanwhile

the adverse drug reactions was observed in two groups.RESULTS:The total effective rate of the observation group was 93.48%（43/46）

significantly higher than that of the control group 76.09%（35/46）

with statistically significant difference（P<0.05）.After treatment

the national institutes of health stroke scale（NIHSS） scores of both groups were significantly lower and Barthel Index（BI） score was significantly higher than that before treatment;after treatment

the NIHSS score of the observation group was significantly lower than that of the control group

while the BI score was significantly higher than that of the control group

with statistically significant differences（P<0.05）.After treatment

the levels of serum brain injury biomarkers [neuron specific enolase（NSE）

S100 β protein] and related inflammatory factors[interleukin（IL）-8

tumor necrosis factor（TNF）-α

hypersensitive C-reactive protein（hs-CRP） ] in both groups were significantly lower than those before treatment

the observation group was significantly lower than the control group

with statistically significant differences（P <0.05）.After treatment

the levels of serum superoxide dismutase（SOD） increased significantly in both groups

while the levels of serum malondialdehyde（MDA） and lipid peroxide（LPO） decreased significantly;the levels of serum SOD in the observation group were significantly higher than those in the control group

and the levels of serum MDA and LPO were significantly lower than those in the control group

with statistically significant differences（P < 0.05）.The incidence of adverse drug reactions in the observation group was 15.22%（7/46）

compared with 17.39%（8/46） in the control group

the difference was not statistically significant（P > 0.05）.CONCLUSIONS:Mouse nerve growth factor for injection combined with oxiracetam in the treatment of HCH may protect the brain tissues and promote the recovery of impaired neurological impairment by downregulating the expression levels of relevant inflammatory factors and correcting the pathway of oxidative stress in the body.The overall efficacy is significant

and the patient is well tolerated.

关键词

注射用鼠神经生长因子奥拉西坦高血压脑出血炎症反应氧化应激脑损伤标志物

Keywords

Mouse nerve growth factor for injectionOxiracetamHypertensive intracerebral hemorrhageInflammatory responseOxidative stressBrain injury biomarkers

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects of Asiaticoside on Cognitive Function,Inflammatory Response, Oxidative Stress and Silent Information Regulator 1/Endoplasmic Reticulum Stress Pathway Protein in Mice with Epileptic

Effects of Low Molecular Heparin on Coagulation Function,Immune Function and Antioxidant Level in Patients with Severe Pneumonia

Efficacy of Liangxue Huoxue Recipe Application in the Treatment of Acute Gouty Arthritis of Dampness-Heat Accumulation Type and Its Effect on Th17/Treg Cell Balance

Efficacy of Internal Iliac Artery Transcatheter Arterial Chemoembolization with Gemcitabine Combined with Cisplatin/Lobaplatin in the Treatment of Muscle Invasive Bladder Urothelial Carcinoma

Effects of Fiberoptic Bronchoalveolar Lavage Combined with Azithromycin on Immune Function, Serum MCP-4, MAPK and CysLTR1 in Children with Mycoplasma Pneumoniae Pneumonia

Related Author

FANG Pingping

LIU Liyan

XIE Yang

LI Zhihua

DU Liye

HE Bing

QI Yongjian

LYU Xiaojing

Related Institution

Dept. of Rehabilitation, Handan Central Hospital

Dept. of Neurology, Handan Central Hospital

Dept. of Respiratory,Jiangsu Traditional Chinese Medicine Hospital

Dept.of Radiology, Shijiazhuang Traditional Chinese Medicine Hospital

Dept.of Orthopedics, Shijiazhuang Traditional Chinese Medicine Hospital

⁰